I will continue my work in Congress to ensure this commonsense legislation is signed into law,
Continue working to secure enactment of the bipartisan bill preventing future deadly TB outbreaks.
Occurrences
I will continue my work to make it law to prevent future deadly TB outbreaks," said Moolenaar.
I will continue my work in Congress to ensure this commonsense legislation is signed into law
Evidence
Latest Action: Senate - 06/24/2025 Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions. Tracker: This bill has the status Passed House. House action on 06/23/2025 was agreed to by voice vote under suspension of the rules.
The bill was introduced by Rep. Moolenaar on 02/06/2025. The latest summary describes it as establishing civil penalties, FDA workshops, a public docket, reporting to Congress, and educational materials to prevent tissue-related TB outbreaks; related bill H.R.340 is listed as a same-congress related measure.
Today, Congressman John Moolenaar and Congresswoman Debbie Dingell’s bipartisan legislation, the Shandra Eisenga Human Cell and Tissue Product Safety Act, was unanimously passed by the House of Representatives.
The bipartisan legislation was passed by the House of Representatives on December 16, 2024, and was introduced in response to a tuberculosis-related death and outbreak concerns.
Assessments
Moolenaar clearly continued working on the bipartisan TB-outbreak-prevention bill by introducing/co-leading the measure and advancing it through the House, including unanimous House passage in June 2025. However, the promise was to secure enactment, and the evidence shows the bill was only passed by the House and then referred to the Senate committee, with no final enactment into law shown. Because he made a substantial legislative effort and achieved meaningful progress short of enactment, this is partial rather than delivered.